Literature DB >> 17327349

Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failure.

Uta C Hoppe1, Nick Freemantle, John G F Cleland, Monique Marijianowski, Erland Erdmann.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17327349     DOI： 10.2337/dc06-2035

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  10 in total

1.  Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people.

Authors:  Celestino Sardu; Raffaele Marfella; Gaetano Santulli
Journal:  J Cardiovasc Transl Res       Date:  2014-02-06       Impact factor: 4.132

2.  Usefulness of hemoglobin A(1c) to predict outcome after cardiac resynchronization therapy in patients with diabetes mellitus and heart failure.

Authors:  Ravi V Shah; Robert K Altman; Mi Young Park; Jodi Zilinski; Jordan Leyton-Mange; Mary Orencole; Michael H Picard; Conor D Barrett; E Kevin Heist; Gaurav Upadhyay; Ranendra Das; Jagmeet P Singh; Saumya Das
Journal:  Am J Cardiol       Date:  2012-05-25       Impact factor: 2.778

3.  [Diabetes and heart failure].

Authors:  Christian A Schneider; Roman Pfister; Erland Erdmann
Journal:  Herz       Date:  2010-05       Impact factor: 1.443

4.  The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma.

Authors:  T Rothhammer; J C Hahne; A Florin; I Poser; F Soncin; N Wernert; A-K Bosserhoff
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

Review 5.  Influence of diabetes on cardiac resynchronization therapy in heart failure patients: a meta-analysis.

Authors:  Hui Sun; Yuqing Guan; Lei Wang; Yong Zhao; Hong Lv; Xiuping Bi; Huating Wang; Xuejing Zhang; Li Liu; Min Wei; Hui Song; Guohai Su
Journal:  BMC Cardiovasc Disord       Date:  2015-03-21       Impact factor: 2.298

6.  Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes.

Authors:  Celestino Sardu; Michelangela Barbieri; Matteo Santamaria; Valerio Giordano; Cosimo Sacra; Pasquale Paolisso; Alessandro Spirito; Raffaele Marfella; Giuseppe Paolisso; Maria Rosaria Rizzo
Journal:  Cardiovasc Diabetol       Date:  2017-06-09       Impact factor: 9.951

Review 7.  Intersection Between Diabetes and Heart Failure: Is SGLT2i the "One Stone for Two Birds" Approach?

Authors:  Qing Zhang; Yu Kang; Siqi Tang; Cheuk-Man Yu
Journal:  Curr Cardiol Rep       Date:  2021-10-13       Impact factor: 2.931

8.  Influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac resynchronization therapy.

Authors:  Ulas Höke; Joep Thijssen; Rutger J van Bommel; Lieselot van Erven; Enno T van der Velde; Eduard R Holman; Martin J Schalij; Jeroen J Bax; Victoria Delgado; Nina Ajmone Marsan
Journal:  Diabetes Care       Date:  2012-12-05       Impact factor: 19.112

Review 9.  Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes.

Authors:  Celestino Sardu; Michelangela Barbieri; Maria Rosaria Rizzo; Pasquale Paolisso; Giuseppe Paolisso; Raffaele Marfella
Journal:  J Diabetes Res       Date:  2015-11-09       Impact factor: 4.011

10.  Differential effect of cardiac resynchronization therapy in patients with diabetes mellitus: a long-term retrospective cohort study.

Authors:  Peter C Kahr; Sander Trenson; Matthias Schindler; Joël Kuster; Philippe Kaufmann; Johanna Tonko; Daniel Hofer; Devdas T Inderbitzin; Alexander Breitenstein; Ardan M Saguner; Andreas J Flammer; Frank Ruschitzka; Jan Steffel; Stephan Winnik
Journal:  ESC Heart Fail       Date:  2020-07-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.